Figures
Abstract
Interleukin (IL)-2, a T-helper 1 (Th1) cell-derived cytokine, which potently modulates dopamine activity and neuronal excitability in mesolimbic structures, is linked with pathological outcomes (e.g., schizophrenia, depression, etc.) that at least partly reflect alterations in central dopaminergic processes. It has been suggested that dopamine neurons undergo pruning during adolescence and abnormalities in pruning predispose individuals to behavioral disorders. Since IL-2 is known as a neurodevelopmental factor affecting associated behavioral processes, the present study tested whether IL-2 can modulate stereotypic behaviors in both the periadolescent and adult periods. This study determined whether IL-2 treatment would produce long-lasting changes in sensitivity to a later challenge with IL-2 or GBR 12909, a highly selective dopamine uptake inhibitor. Four experiments were conducted. Firstly, a decrease in novelty-induced stereotypic behavior was observed in BALB/c periadolescent mice (38 days of age) following IL-2 administration (0.4 µg/2 ml) relative to vehicle control. In the second experiment, an initial dose of IL-2 was given in the periadolescent period, but did not affect rearing responses. A second dose of IL-2 given to the animals 30 days later as adults, resulted in a significant increase in rearing behaviors relative to control animals. In the third experiment, separate groups of experimental and control mice were administered GBR 12909, a highly selective dopamine reuptake inhibitor, 30 days following treatment with either IL-2 or vehicle. It was noted that this experimental group, which initially received IL-2, exhibited stereotypy, as evidenced by increased sniffing behavior. A fourth experiment revealed that IL-2 administered in periadolesecence and adulthood had no effect on other motor responses, indicating that IL-2 selectively modulates selective stereotypic behaviors. The results provide evidence, for the first time, that long-term changes in stereotypy in periadolescent mice are linked to an IL-2 mechanism, possibly utilizing dopamine.
Citation: Rankin JS, Zalcman SS, Zhu Y, Siegel A (2013) Short- and Long-Term Effects of Interleukin-2 Treatment on the Sensitivity of Periadolescent Female Mice to Interleukin-2 and Dopamine Uptake Inhibitor. PLoS ONE 8(5): e64473. https://doi.org/10.1371/journal.pone.0064473
Editor: Makoto Sato, University of Fukui, Faculty of Medical Sciences, Japan
Received: January 25, 2013; Accepted: April 15, 2013; Published: May 24, 2013
Copyright: © 2013 Rankin et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: S.S. Zalcman received funds provided by the ‘Society for Woman’s Health Research’ to conduct this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: Co-author Allan Seigel is a PLOS ONE Editorial Board member. This does not alter the authors’ adherence to all the POS ONE policies on sharing data and materials.
Introduction
Exposure to stress during critical neurodevelopmental periods can induce long-term effects on brain and behavior. For example, maternal stressor exposure in rats leads to abnormalities in the thickness of the cerebral cortex, while exposure to stress during the perinatal period can lead to long-term consequences on behavior and reproductive capacity [1]. The majority of the literature investigating long-term behavioral consequences of stressor exposure during developmental periods focuses on prenatal and early life periods, but very little is known about how stressor exposure during adolescence affects adult behavioral response to challenges during adulthood.
During adolescence, individuals undergo a process known as “synaptic pruning”, or a loss of the excess connections between neurons overproduced early in development [2]–[4]. One implication of this “synaptic pruning” is aberrant pruning incited by immune or environmental factors during critical windows in development, which has been associated in the development of schizophrenia, among other neuropsychological conditions [3], [5]. Attention deficit disorder (ADD), another important developmental aberration, relates to dopaminergic cells, with alterations in pruning of dopaminergic synapses and receptors during adolescence. As such, periadolescent rodents (30–45 days of age) that are concurrently experiencing pruning have been thought of as a model for several behavioral disorders in human populations; these include schizophrenia and drug-abuse, both of which become apparent during an analogous time period in human adolescence [6]–[8]. Evidence from various lines of research suggests that stressors and immune-derived stimuli during critical developmental periods may have profound short- and long-term consequences on behavior. However, little is currently known about the mediators in this process.
Recent data suggests that infection or inflammation, like psychogenic or physical stressors, during the course of gestation may predispose individuals to pathologies of the meso-limbic and -cortical dopamine systems, such as an increased expression of stereotypic behavior (excessive functional motor behaviors), deficits in learning and hypersensitivity to drugs of abuse [9], [10]. It is generally thought that cytokines released during the immune response play an important role in mediating such effects. Concerning IL-2, it is a cytokine produced by T-helper cells involved in immune response, which has been shown to directly alter dopaminergic activity in the meso-limbic and -striatal pathways, thereby altering behaviors associated with these systems. This leads to speculation as to the interplay between stressors, IL-2 and behavioral alteration exacted through the dopaminergic pathway.
IL-2 modulates dopamine levels during pre- and post-natal periods, as well as in adulthood, and dopamine-mediated behaviors during adulthood. Given that a major developmental period for dopaminergic neurons occurs during adolescence (i.e., when the pruning process occurs), IL-2 has also been shown to alter development of dopaminergic systems. For example, De Araujo et al. and McAfoose et al. showed that IL-2 increases the survival and synaptogenesis of dopaminergic neurons during development [11], [12]. In parallel with this finding, it has been posited that cytokines, in their regulation of synaptic plasticity, may be causative agents of neuropsychiatric syndromes.
There is a dearth of information, however, on the effects of cytokines on the adolescent brain and its maturation. The effect of immune mediators (e.g. IL-2) during a window period of vulnerability, such as neural restructuring during adolescence, on these systems is therefore of great interest. Accordingly, the present study tested the hypothesis that IL-2 modulates stereotypy when administered in periadolescent mice and such effects are linked to a dopamine mechanism. This hypothesis was examined by determining the behavioral effects that IL-2 exerts on periadolescent female mice in an initial challenge and to a subsequent challenge in adulthood with IL-2 or GBR-12909, a dopamine reuptake inhibitor, which may also function as a psychostimulant.
Materials and Methods
Subjects
All methods and procedures were approved by Institutional Animal Care and Use Committee (IACUC) of UMDNJ-NJMS, Newark, NJ. A total of 36 female BALB/c mice (Charles River Laboratories, Wilmington, MA), 38 days of age (mean initial weight of 18.2 g ±0.33 g) were bred for use in this study. This strain of mouse was selected based on our previous investigations from our laboratory in the examination of neurochemical and behavioral changes and age was selected based on what is defined as adolescence in mice [8], [13]. The animals were housed individually in polypropylene ‘shoebox’ cages, maintained on a 12-h light/12-h dark cycle (7 am–7 pm) and permitted ad libitum access to food and water. Experiments were conducted during the light phase.
Reagents
Recombinant, murine, and carrier-free IL-2 (PeproTech Inc., Rock Hill, NJ) was dissolved in sterile saline and injected subcutaneously (s.c.) at doses of 0.4 µg/mouse in approximately 2 mL. Dose and route of administration were chosen based on our demonstration that exploration was significantly increased in this strain of adult male mouse following a single s.c. injection of 0.4 µg of IL-2 [14].
GBR 12909 (1-{2-[bis(4-fluorophenyl)-methoxy]ethyl}-4-(3-phenylpropyl)piperazine) (Tocris-Cookson Inc., Ballwin, MO), a potent and highly selective inhibitor of dopamine uptake, was dissolved in sterile saline and injected intraperitoneally (i.p.) at a dose of 7 mg/kg. Peripheral or central injections of GBR 12909 induce behavior-activating effects, and this dopamine agonist shares properties that are associated with psychomotor stimulants that also inhibit dopamine uptake.
Behavioral Testing
Animals were tested in a cage outfitted with a TruScan Activity Monitoring System (Coulbourn Instruments). The TruScan measured various data points, namely: Ambulatory Distance–The total of all horizontal movements minus the total distance of stereotypic moves. Jumps–The total number of time, the subject loses contact with the horizontal floor plate, not exceeding 2 seconds. Counterclockwise Turns (CCW)–counterclockwise turns into 4 sequential quadrants in the center of the cage. Vertical Plane (VP) Moves–Total movement in the vertical plane. VP Entries–The total # of times any part of the animal entered the vertical plane. VP Time–The total time any part of the animal spent in the vertical plane. VP Stereotypy (STPY) Moves–The total # of coordinate changes in the vertical dimension, <0.75 cm spaces apart in the horizontal dimension, and back to the starting point, not exceeding 2 seconds apart. Three such movements must be made before recording starts; thereafter, the 3 movements are included in the total # of moves. When the subject moves outside of the region, or does not move within them for 2 seconds, recording stops and resets. VP STPY Time–The total time of all of the episodes of stereotypic episodes defined in VP STPY Moves. Center Time–The total time spent outside of a 1.9 cm margin of the walls. Center Distance–The total of all X–Y coordinate changes occurring outside of a 1.9 cm margin of the walls. Margin Time/Distance–Center, substituted with “within a 1.9 cm margin”. Center vs. Margin (C vs. M) Time–The ratio of Center Time/Margin Time. C vs. M Distance–The ratio of Center Distance/Margin Distance.
Test sessions were also taped with a VHS camera and scored at a later date. Scoring was measured with a stopwatch for time (Sec) spent: rearing, rearing against the wall, grooming and sniffing; with less than 3 sec being recorded for number of episodes and 3 sec or more recording the time duration, except for in the instance of total numbers where all instances were counted. Use of a stopwatch was based on our demonstration that IL-2 induced significantly comparable effects on this behavior in experiments using a programmed computer or a stopwatch, while 3 sec as a threshold for time duration was chosen based on our previous experiments showing the effects of IL-2. A rearing episode was defined as a subject lifting both front limbs off the ground, whereas a rearing episode against the wall consisted of lifting both front limbs and leaning against the cage wall. We selected these stereotypic measures based on our findings that IL-2 treatment induces an increase in stereotypic motor behavior, showing that those behaviors may be attributed to elements of an activated immune system and their utility as animal analogous of repetitive stereotypic movements [15].
In experiment 1, the mice (n = 18/group) received a single subcutaneous (s.c.) injection of IL-2 0.4 µg or saline 300 µL and immediately thereafter were individually placed into a test cage for 2 hours. Measurements were taken in 2-minute epochs once every 20 minutes.
In experiment 2, we determined if periadolescent IL-2 treatment would proactively influence behavioral responses to a later injection of IL-2 (i.e. 1-month later). Accordingly, 12 mice received saline and 12 mice received IL-2 (0.4 µg, s.c.). Immediately following these injections, the mice were individually placed into the test cage, and behavior was determined, as described.
In experiment 3, we determined if periadolescent IL-2 treatment would proactively influence behavioral responses to a later injection of GBR 12909 (i.e. 1-month later). Accordingly, in Experiment 3, six mice received saline and six mice received a single intraperitoneal (i.p.) injection of GBR (7 mg/kg, i.p.).
Immediately after each injection, the animals were individually placed into their respective activity box for 2 hours, where they were recorded on TruScan and filmed and scored, at a later date, as described. Illustrated data for this experiment represent activity scores for entire 2-hour sessions.
Statistics
Data was analyzed with one-way ANOVA’s (i.e. Experimental vs. Control group) - and two-way ANOVA’s (i.e., variable A: experimental versus control group, and B: effects over time irrespective of group) testing selective stereotypic motor and related responses using Excel software (Microsoft Co., Redmond, Wa.).
Results
Effects of IL-2 on Novelty-induced Behavioral Activity
In this experiment, the goal was to determine the effects of IL-2 administration upon motor responses, which included: VP stereotypy time (VP STPY Time), turns, ambulatory distance and center vs. margin time. The results indicated a significant decrease in novelty-induced exploratory behavior as evidenced by reductions in: VP STPY Time [F1, 32 = 6.56, p<0.05] (Fig. 1a.), Jumps [F1, 32 = 6.92, P<0.05] (Fig. 1b.); and CCW turns [F1, 33 = 5.82, p<0.05] (Fig. 1c.). Interestingly, there was no significant effect on locomotion (i.e. Ambulatory distance [F1, 33 = 1.38, p = 0.25], or location in the test cage (C vs. M Time [F1, 33 = 0.52, p = 0.48] and C vs. M Distance [F1, 33 = 1.77, p = 0.19]) (figure not shown).
Mean (± S.E.M.) activity scores (A. Jumps; B. VP STPY Time; C. CCW Turns) following a single injection of saline or IL-2 (0.4 µg/mouse, s.c.). Mice were exposed to the test cage immediately following cytokine administration. *p<0.05.
Effects of Subsequent IL-2 Challenge on Rearing Behavior
In this experiment, the goal was to determine if a subsequent challenge to IL-2 administered one month later would exert a different effect on behavior, which included various modes of rearing behavior, jumps, turns and VP STPY Time.
Administration of IL-2 during the initial (periadolescent) period had no effect on rearing behavior: Number of Rearing Episodes (less than 3 sec) [F1, 33 = 0.27, p = 0.11] (Fig. 2a.); Number of Rearing Against Wall Episodes (less than 3 sec) [F1, 15 = 0, p = 1] (Fig. 2b.); Total Rearing Number [F1, 33 = 0.28, p = 0.59] (Fig. 2c.); and Total Rearing Time (Sec) [F1, 33 = 0.08, p = 0.78] (Fig. 2d.).
Mean (± S.E.M.) activity scores (A. Number of rearing episodes within 3 sec; B. Number of rearing against wall episodes within 3 sec; C. Total number of rearing episodes; D. Total time spent rearing (sec)) following a single injection of saline or IL-2 (0.4 µg/mouse, s.c.) and those tested 30 days later with single injection of IL-2 (0.4 µg/mouse, s.c.) administered 30 days later, as described in the figure with “+30 days” designation. Mice were exposed to the test cage immediately following cytokine administration. *p<0.05.
When tested one month later after a subsequent challenge with IL-2, the results indicated significant increases in novelty-induced exploratory behavior, as evidenced by increases in: Number of Rearing Episodes (less than 3 sec) [F1, 18 = 4.96, P<0.05] (Fig. 2a.); Number of Rearing Episodes Against Wall (less than 3 sec) [F1, 18 = 10.19, p<0.005] (Fig. 2b.); Total Number of Rearing Episodes [F1, 19 = 5.66, p<0.05] (Fig. 2c.); and Total Rearing Time (Sec) [F1, 18 = 5.34, p<0.05] (Fig. 2d.).
Of further importance, the stereotypic behaviors that were significantly altered in mice receiving a single injection of IL-2 during periadolescence were not significantly altered by a second IL-2 injection, including: Jumps [F1, 20 = 1.46, p = 0.5]; CCW turns [F1, 22 = 0.64, p = 0.43]; and VP STPY Time [F1, 21 = 0.63, p = 0.44] (not shown).
Effects of Selective Dopamine Uptake Inhibitor on Sniffing Behavior
The objective of the third experiment was to determine whether administration of GBR 12909, a highly selective dopamine uptake inhibitor, would exert a different effect on treatment versus vehicle. The results indicated a significant increase in sensitivity upon the behaviorial-stimulating effects of GBR 12909. In particular, compared with mice that received only saline during periadolescence and GBR 12909 one-month later, mice that received IL-2 during periadolescence plus GBR 12909 one-month later showed significant increases in sniffing. A two-way Treatment×Time Point after GBR 12909 ANOVA revealed a significant main effect of Treatment [F1, 5 = 5.17, p<0.05] (Fig. 3). IL-2 administration did not alter sniffing responses prior to administration of GBR. Moreover, activity, rearing, as well as other measures of stereotypic behaviors, were not significantly altered after GBR administration (not shown).
Mean (± S.E.M.) activity score of GBR 12909-stimulated sniffing time. Mice received a single injection of saline or IL-2 (0.4 µg/mouse, s.c.), and were tested 30 days later with GBR 12909 (7 mg/kg, i.p.). Mice were exposed to the test cage immediately following GBR administration. Note that the effect was initially observed at 80-minutes post-injection (shown with arrow). *p<0.05.
Absence of Non-specific Motor Effects of IL-2
In order to determine whether or not the results observed in the experiments shown above were due to non-specific effects of IL-administration, the following data were compared and shown in Figs. 4a and 4b, as a means of displaying the specificity of the behaviors exhibited. Both ambulatory distance and vertical plane activity were not significantly different between groups receiving initial administration of IL-2 versus saline ([F1, 33 = 1.38, p = 0.2] and [F1, 33 = 2.7, p = 0.11], respectively). Likewise, when the same groups both received IL-2 one-month later, there were no significant differences in these motor responses tested ([F1, 22 = 1.47, p = 0.24] and [F1, 22 = 0.66, p = 0.55], respectively). Therefore, this finding indicates that IL-2 had a selective effect upon the specific motor responses whose results were described above in this study.
A second injection of IL-2 30-days later also did not alter these responses. Mean (± S.E.M.) activity scores ((A). Ambulatory distance (cm); (B). Number of vertical activity sessions) following a single injection of saline or IL-2 (0.4 µg/mouse, s.c.) and those tested 30 days later with single injection of IL-2 (0.4 µg/mouse, s.c.), as described in figure with “+30 days” designation. p>0.05 NS [NS = non-significance].
Discussion
In the present study, we showed for the first time that cytokine administration induces significant and long-lasting behavioral variations in periadolescent mice. Specifically, a single injection of IL-2 induced significant decreases in novelty-induced stereotypic behavior (Figs 1 and 2), possibly indicating a “depressive-like” state, which did not significantly change overall activity in the horizontal or vertical directions (Fig. 4). This finding therefore reveals an absence of non-specific motor effects of IL-2 upon stereotypic behaviors tested in this study. Of further importance, adult responses to IL-2 or psychostimulant challenge (i.e., GBR 12909) were significantly enhanced in mice with a history of IL-2 treatment during periadolescence. Thus, a single injection of IL-2 during the periadolescent period has important consequences on adult responses. This suggests a temporal specificity upon selective behavioral motor responses that are associated with specific ages of the animals examined in this study. In addition, based upon the recent findings of Zalcman et al., it is also likely that these effects are mediated through specific anatomical loci and their associated pathways [15].
Of central importance is the question of whether IL-2 can influence behavioral processes via their influence on brain function. The neurochemical and behavioral effects of peripherally applied IL-2 are related to its ability to cross the blood-brain-barrier (BBB), but its mode of entry is unclear. In adults, the molecular weights of cytokines are sufficiently large to prevent them from crossing the BBB alone to activate neurons by specific receptor mechanisms or to produce corticotropin-releasing hormone (CRH). In adolescents, the blood brain barrier (BBB) may be more porous and underdeveloped and therefore, pro-inflammatory cytokines may enter through the “leakier” area, act on brain regions lacking one of these barriers or they may enter the brain via “specific uptake systems” [16]–[18]. Under conditions when IL-2 is able to cross the BBB, it has been shown to influence dopamine turnover in the prefrontal cortex and dopamine release in the nucleus accumbens [19]. There is also evidence for entrance of Th1-Lymphocytes directly into the CNS across the BBB in experimental allergic encephalomyelitis (EAE) and other experimental models, which may be affected by inflammatory states [20], [21].
Factors Affecting Stereotypic behavior in Periadolescent Mice
Compared with mice that received saline during the periadolescent period, young mice with a history of IL-2 treatment showed significant increases in rearing behavior following a single injection of IL-2 during young adulthood. Notably, IL-2 did not induce this effect when administered during periadolescence; whereupon the following conclusions can be made: (1) The individual’s initial response to IL-2 was not sensitized upon subsequent exposure to the cytokine; and (2) one cannot predict the animal’s behavioral response to a second injection of IL-2 based on its initial behavioral responses to the cytokine. We suggest that changes in relevant neural pathways (e.g., meso-limbic and –striatal systems) induced by IL-2 administration could serve as better predictors.
Dopamine
The possibility that IL-2 acts through a neurochemical mechanism in the brain has recently been established, in which a specific form of aggressive behavior (i.e., defensive rage) is powerfully modulated by IL-2 acting through GABAA receptors in the medial hypothalamus and by substance P- neurokinin (NK1) receptors in the midbrain periaqueductal gray [22], [23]. Therefore, from the findings of the present study, it is reasonable to suggest that IL-2′s effects upon stereotypy are also mediated through a neurotransmitter mechanism, namely via dopamine receptors. It was observed that GBR 12909-induced increases in stereotypic behavior in adult female mice were potentiated in mice that received a single injection of IL-2 in periadolescence, implying that IL-2 produced long-lasting changes in the sensitivity of meso-limbic and –striatal dopaminergic activity. That responses to IL-2 or GBR 12909 were further augmented in mice with a history of IL-2 treatment during adolescence implies that an increase in IL-2 during that period has profound effects on the sensitivity, and perhaps development, of relevant neural systems.
The relationship between dopamine and various forms of motivated and abnormal emotional behavior has been studied extensively. There is a positive relationship between rearing behavior, IL-2 [14], [24] and dopamine in the ventral striatum [25], which is of interest because of its relationship between motor functions and goal-seeking/motivational responses, in addition to the fact that this region of the forebrain projects to other areas involved in motor and tic disturbances [3], [15]. Therefore, it is possible that dopamine’s effects upon both motor and emotional processes are mediated in part through a cytokine mechanism.
A progressive number of studies show relationships between inflammatory processes, cytokines, and neuropsychiatric disorders in humans (i.e. depression, schizophrenia) [10], [26]–[31]. IL-2 influences monoaminergic neurotransmission in the CNS and is often linked to psychological diseases such as depression, or anxiety disorders [32]–[34]. IL-2 and soluble IL-2 receptors are elevated in the CSF of schizophrenic patients [19], where increased IL-2 may be related to positive symptoms and sIL-2R, a modulator of IL-2 levels. These levels may reflect an inhibitory process associated with IL-2 related to increases in dopaminergic transmission [35].
Inasmuch as IL-2 treatment administered during periadolescence increased sensitivity to the motor activating effects of IL-2 and GBR 12909, coupled with the fact that the initial exposure to IL-2 occurred during the periadolescent period, we suggest that IL-2 influences the pruning process during which dopaminergic synapses and receptors are eliminated. To be sure, this is highly speculative; nevertheless, IL-2 is known to affect the development of dopaminergic neurons during pre/post-natal periods [11], [12], [36]–[38].
Anatomical Considerations
Based upon recently published work in our laboratory, there is now evidence that the behavioral effects of IL-2 upon stereotypy is mediated primarily through neurons in the neostriatum, nucleus accumbens and motor regions of cortex [15], [39]. IL-2 is synthesized centrally, where it is distributed throughout the CNS. In addition, increased c-Fos expression (suggesting increased metabolic activity) in these forebrain neurons following stereotypic behavior overlap extensively with soluble IL-2 receptor labeling in the same regions of forebrain, which suggest that these areas are associated with several of the behavioral motor processes examined in the present study [15], [24], [40]–[42].
Therefore, these observations, coupled with the findings of the present study, would suggest that these regions of the forebrain might provide the substrate for the enhanced effects of IL-2 upon stereotypy. The precise physiological mechanisms by which stereotyped behaviors are modulated by IL-2 remain to be elucidated.
Other Possible Factors
IL-2 has been shown to alter hormone levels (i.e. CRH, ACTH and their down-stream mediators) and modulate the hypothalamic-pituitary-adrenocortical (HPA)-axis [16], [43]. Given this fact and that glucocorticoids regulate dopaminergic cell activity, it should also be considered that IL-2 induced potentiation of the HPA response played a role in long-term effects associated with this cytokine.
What is also known is that the periadolescent period is a critical time for development of the HPA-gonadal axis and its effects on behavior. As opposed to the postnatal period, which may exhibit long-term consequences for male mice, female mice exposed to stressors during adolescence may cause alterations in behavior during adulthood, which may be attributed to differential levels of microglia within the brain based on sex hormone concentration [44]. Furthermore, it has been shown that certain female sex hormones affect neurotransmitter systems in various brain regions (e.g., dopamine in the dorsal striatum) [43], [45], [46]. Although, we did not control for random hormonal cycling, and while the mice employed in the present study could have been randomly cycling females, we nevertheless observed significant effects between groups, suggesting a possible significant role played by dopamine in this process.
In summary, we provide novel evidence that a single injection of IL-2 in periadolescent female mice significantly modifies behavioral responses to produce a long-lasting increase in sensitivity to later challenges with IL-2 or GBR 12909. It remains to be seen, however, whether IL-2 in periadolescent mice modifies dopamine, the HPA axis and/or cortisol levels. We suggest that alterations in IL-2 in periadolescence increases vulnerability to the expression of psychopathological outcomes involving increased repetitive stereotypic behaviors that may be associated with abnormalities in the pruning of dopaminergic neurons and synapses during adolescence, This has significant implications on our understanding of adolescent and periadolescent behavior in that we demonstrated that administration of a pro-inflammatory agent during the periadolescent period induces significant unique effects during this time period and has long-term behavioral consequences.
Future studies would require measurement of cortisol levels to differentiate between the effects of IL-2 and GBR in modulating the stress response, which could include diminished functions of the HPA-axis or increases in dopaminergic functions. Additionally, tests would further require an analysis of the labeling patterns of c-Fos following stereotypic and related responses to localize the brain regions involved in cortisol neuronal activation, as well as direct measurement of dopamine and its receptors in response to IL-2 administration.
Acknowledgments
After data for this experiment was collected, Dr. Zalcman prepared an outline of the manuscript, but soon afterwards we were deeply saddened to learn that he suddenly passed away. Dr. Zalcman played a key part in the design of the experiment and the procurement of funds that supported this project.
The authors would like to thank Ankur Patel, Anthony Gotay, Adeola Yetunde and Praveen Ganti Ranganath for their assistance in data collection.
Author Contributions
Conceived and designed the experiments: SSZ. Performed the experiments: SSZ YZ JSR. Analyzed the data: SSZ JSR AS. Contributed reagents/materials/analysis tools: SSZ. Wrote the paper: JSR AS.
References
- 1. Stewart J, Kolb B (1988) The effects of neonatal gonadectomy and prenatal stress on cortical thickness and asymmetry in rats. Behav Neural Biol 49: 344–360.
- 2. Mirnics K, Middleton FA, Lewis DA, Levitt P (2001) Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse. Trends Neurosci 24: 479–486.
- 3. Paus T, Keshavan M, Giedd JN (2008) Why do many psychiatric disorders emerge during adolescence? Nat Rev Neurosci 9: 947–957 .
- 4. Rolls ET, Deco G (2011) A computational neuroscience approach to schizophrenia and its onset. Neurosci Biobehav Rev 35: 1644–1653 .
- 5. Faludi G, Mirnics K (2011) Synaptic changes in the brain of subjects with schizophrenia. Int J Dev Neurosci 29: 305–309 .
- 6. Laviola G, Macrì S, Morley-Fletcher S, Adriani W (2003) Risk-taking behavior in adolescent mice: psychobiological determinants and early epigenetic influence. Neurosci Biobehav Rev 27: 19–31.
- 7. Adriani W, Laviola G (2004) Windows of vulnerability to psychopathology and therapeutic strategy in the adolescent rodent model. Behav Pharmacol 15: 341–352.
- 8. Smith RF (2003) Animal models of periadolescent substance abuse. Neurotoxicol Teratol 25: 291–301.
- 9. Nawa H, Takei N (2006) Recent progress in animal modeling of immune inflammatory processes in schizophrenia: implication of specific cytokines. Neurosci Res 56: 2–13 .
- 10. Watanabe Y, Someya T, Nawa H (2010) Cytokine hypothesis of schizophrenia pathogenesis: evidence from human studies and animal models. Psychiatry Clin Neurosci 64: 217–230 .
- 11. De Araujo EG, Da Silva GM, Dos Santos AA (2009) Neuronal cell survival: the role of interleukins. Ann N Y Acad Sci 1153: 57–64 .
- 12. McAfoose J, Baune BT (2009) Evidence for a cytokine model of cognitive function. Neurosci Biobehav Rev 33: 355–366 .
- 13. Zalcman S, Green-Johnson JM, Murray L, Wan W, Nance DM, et al. (1994) Interleukin-2-induced enhancement of an antigen-specific IgM plaque-forming cell response is mediated by the sympathetic nervous system. J Pharmacol Exp Ther 271: 977–982.
- 14. Zalcman S, Murray L, Dyck DG, Greenberg AH, Nance DM (1998) Interleukin-2 and -6 induce behavioral-activating effects in mice. Brain Res 811: 111–121.
- 15. Zalcman SS, Patel A, Mohla R, Zhu Y, Siegel A (2012) Soluble cytokine receptors (sIL-2Rα, sIL-2Rβ) induce subunit-specific behavioral responses and accumulate in the cerebral cortex and basal forebrain. PLoS ONE 7: e36316 .
- 16. Kerr D, Krishnan C, Pucak ML, Carmen J (2005) The immune system and neuropsychiatric diseases. Int Rev Psychiatry 17: 443–449 .
- 17. Gądek-Michalska A, Bugajski J (2010) Interleukin-1 (IL-1) in stress-induced activation of limbic-hypothalamic-pituitary adrenal axis. Pharmacol Rep 62: 969–982.
- 18. Bilbo SD, Schwarz JM (2012) The immune system and developmental programming of brain and behavior. Front Neuroendocrinol 33: 267–286 .
- 19. Zalcman SS (2001) Interleukin-2 potentiates novelty- and GBR 12909-induced exploratory activity. Brain Res 899: 1–9.
- 20. Brown KA (2001) Factors modifying the migration of lymphocytes across the blood-brain barrier. Int Immunopharmacol 1: 2043–2062.
- 21. Banks WA, Niehoff ML, Ponzio NM, Erickson MA, Zalcman SS (2012) Pharmacokinetics and modeling of immune cell trafficking: quantifying differential influences of target tissues versus lymphocytes in SJL and lipopolysaccharide-treated mice. J Neuroinflammation 9: 231 .
- 22. Bhatt S, Zalcman S, Hassanain M, Siegel A (2005) Cytokine modulation of defensive rage behavior in the cat: role of GABAA and interleukin-2 receptors in the medial hypothalamus. Neuroscience 133: 17–28 .
- 23. Bhatt S, Siegel A (2006) Potentiating role of interleukin 2 (IL-2) receptors in the midbrain periaqueductal gray (PAG) upon defensive rage behavior in the cat: role of neurokinin NK(1) receptors. Behav Brain Res 167: 251–260 .
- 24. Karrenbauer BD, Ho Y-J, Ludwig V, Löhn J, Spanagel R, et al. (2009) Time-dependent effects of striatal interleukin-2 on open field behaviour in rats. J Neuroimmunol 208: 10–18 .
- 25. Ikemoto S (2002) Ventral striatal anatomy of locomotor activity induced by cocaine, D-amphetamine, dopamine and D1/D2 agonists. Neuroscience 113: 939–955.
- 26. Saetre P, Emilsson L, Axelsson E, Kreuger J, Lindholm E, et al. (2007) Inflammation-related genes up-regulated in schizophrenia brains. BMC Psychiatry 7: 46 .
- 27.
Rawdin B, Mellon SH, Dhabhar FS, Epel ES, Puterman E, et al.. (2012) Dysregulated relationship of inflammation and oxidative stress in major depression. Brain Behav Immun. doi:10.1016/j.bbi.2012.11.011.
- 28. Stertz L, Magalhães PVS, Kapczinski F (2013) Is bipolar disorder an inflammatory condition? The relevance of microglial activation. Curr Opin Psychiatry 26: 19–26 .
- 29.
Karson A, Demirtaş T, Bayramgürler D, Balcı F, Utkan T (2012) Chronic Administration of Infliximab (TNF-Alpha Inhibitor) Decreases Depression and Anxiety-like Behaviour in Rat Model of Chronic Mild Stress. Basic Clin Pharmacol Toxicol. doi:10.1111/bcpt.12037.
- 30.
Elamin I, Edwards MJ, Martino D (2012) Immune dysfunction in Tourette syndrome. Behav Neurol. doi:10.3233/BEN-120295.
- 31. Angelidou A, Asadi S, Alysandratos K-D, Karagkouni A, Kourembanas S, et al. (2012) Perinatal stress, brain inflammation and risk of autism-Review and proposal. BMC Pediatr 12: 89 .
- 32. Nance DM, Sanders VM (2007) Autonomic innervation and regulation of the immune system (1987–2007). Brain Behav Immun 21: 736–745 .
- 33. Sanders VM, Straub RH (2002) Norepinephrine, the beta-adrenergic receptor, and immunity. Brain Behav Immun 16: 290–332.
- 34. Rook GAW, Lowry CA (2008) The hygiene hypothesis and psychiatric disorders. Trends Immunol 29: 150–158 .
- 35. Igue R, Potvin S, Bah R, Stip E, Bouchard R-H, et al. (2011) Soluble interleukin-2 receptor levels correlated with positive symptoms during quetiapine treatment in schizophrenia-spectrum disorders. Prog Neuropsychopharmacol Biol Psychiatry 35: 1695–1698 .
- 36. Stephan AH, Barres BA, Stevens B (2012) The complement system: an unexpected role in synaptic pruning during development and disease. Annu Rev Neurosci 35: 369–389 .
- 37. Marra C, Gomes Moret D, De Souza Corrêa A, Chagas da Silva F, Moraes P, et al. (2011) Protein kinases JAK and ERK mediate protective effect of interleukin-2 upon ganglion cells of the developing rat retina. J Neuroimmunol 233: 120–126 .
- 38. Shen Y, Liu S-S, Zhan M-Y, Luo J-H, Zhu L-J (2010) Interleukin-2 enhances dendritic development and spinogenesis in cultured hippocampal neurons. Anat Rec (Hoboken) 293: 1017–1023 .
- 39. Zhang D, Patel A, Zhu Y, Siegel A, Zalcman SS (2012) Anti-streptococcus IgM antibodies induce repetitive stereotyped movements: cell activation and co-localization with Fcα/μ receptors in the striatum and motor cortex. Brain Behav Immun 26: 521–533 .
- 40. Hanisch UK, Quirion R (1995) Interleukin-2 as a neuroregulatory cytokine. Brain Res Brain Res Rev 21: 246–284.
- 41. Kazakova TB, Barabanova SV, Novikova NS, Glushikhina MS, Khavinson VK, et al. (2005) Synthesis of IL-2 mRNA in cells of rat hypothalamic structures after injection of short peptides. Bull Exp Biol Med 139: 718–720.
- 42. Korneva EA, Barabanova SV, Golovko OI, Nosov MA, Novikova NS, et al. (2000) C-fos and IL-2 gene expression in rat brain cells and splenic lymphocytes after nonantigenic and antigenic stimuli. Ann N Y Acad Sci 917: 197–209.
- 43. Bhatt S, Bhatt R, Zalcman SS, Siegel A (2008) Role of IL-1 beta and 5-HT2 receptors in midbrain periaqueductal gray (PAG) in potentiating defensive rage behavior in cat. Brain Behav Immun 22: 224–233 .
- 44. Schwarz JM, Bilbo SD (2012) Sex, glia, and development: interactions in health and disease. Horm Behav 62: 243–253 .
- 45. Duchesne A, Dufresne MM, Sullivan RM (2009) Sex differences in corticolimbic dopamine and serotonin systems in the rat and the effect of postnatal handling. Prog Neuropsychopharmacol Biol Psychiatry 33: 251–261 .
- 46. Camacho-Arroyo I, López-Griego L, Morales-Montor J (2009) The role of cytokines in the regulation of neurotransmission. Neuroimmunomodulation 16: 1–12 .